Foundation for the National Institutes of Health
The Foundation for the National Institutes of Health is a not-for-profit, 501 charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).
Research programs
The FNIH collaborates on biomedical research programs to advance breakthrough scientific discoveries. Research partnerships include:- Accelerating COVID-19 Therapeutic Interventions and Vaccines : a public–private partnership led by the National Institutes of Health and coordinated by the Foundation for the National Institutes of Health to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and COVID-19 treatments. ACTIV brings together NIH with the United States Department of Health and Human Services agencies, including the Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention and the U.S. Food and Drug Administration ; other government agencies, including the Department of Defense and Department of Veterans Affairs ; the European Medicines Agency ; and representatives from academia, philanthropic organizations and biopharmaceutical companies including Pfizer, Roche and Takeda.
- Accelerating Medicines Partnership: brings together the resources of the NIH and industry to improve the understanding of disease pathways and facilitate better selection of targets for treatment. Through the partnership, research programs have been established across major disease areas including Alzheimer's disease, Type 2 diabetes and immune-mediated disorders.
- Alzheimer's Disease Neuroimaging Initiative : helps manage the Alzheimer's Disease Neuroimaging Initiative, a public-private partnership that has identified and validated biological markers that indicate its onset and progression. The study tracks volunteers at clinical sites with normal cognition, mild cognitive impairment and Alzheimer's disease to create a widely-available database of imaging, biochemical and genetic data, which can lay the groundwork for Alzheimer's discoveries.
- Biomarkers Consortium: a public-private biomedical research partnership managed by the FNIH. Launched in 2006, the BC seeks regulatory approval for biological markers to support new drug development, preventive medicine and medical diagnostics.
- Grand Challenges in Global Health Initiative & Continued Vector Research: The FNIH combats mosquito-borne disease through an extension of the Grand Challenges in Global Health initiative, which was supported by the Bill & Melinda Gates Foundation. In ongoing partnership with the Foundation, the FNIH continues work through programs such as Vector-based Control of Transmission: Discovery Research and Support Functions for Development of New Technologies for Controlling Transmission of Mosquito-Borne Diseases.